Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C24H26N4O3S.3H2O.H2O4S |
Molecular Weight | 1053.231 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.OS(O)(=O)=O.O=C(N1CCN(CC2CC2)CC1)C3=CC=C(NS(=O)(=O)C4=CC=CC5=C4N=CC=C5)C=C3.O=C(N6CCN(CC7CC7)CC6)C8=CC=C(NS(=O)(=O)C9=CC=CC%10=C9N=CC=C%10)C=C8
InChI
InChIKey=DMRIPASJCJRBMV-UHFFFAOYSA-N
InChI=1S/2C24H26N4O3S.H2O4S.3H2O/c2*29-24(28-15-13-27(14-16-28)17-18-6-7-18)20-8-10-21(11-9-20)26-32(30,31)22-5-1-3-19-4-2-12-25-23(19)22;1-5(2,3)4;;;/h2*1-5,8-12,18,26H,6-7,13-17H2;(H2,1,2,3,4);3*1H2
DescriptionSources: https://www.google.com/patents/WO2011002817A1Curator's Comment: description was created based on several sources, including
http://www.medkoo.com/products/12088
Sources: https://www.google.com/patents/WO2011002817A1
Curator's Comment: description was created based on several sources, including
http://www.medkoo.com/products/12088
Mitapivat, also known as PKM2 activator 1020, is an activator of a pyruvate kinase PKM2, an enzyme involved in glycolysis. It was disclosed in a patent publication WO 2011002817 A1 as compound 78.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1075189 Sources: https://www.google.com/patents/WO2011002817A1 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.google.com/patents/WO2011002817A1
Activity of PKM2 was measured as changes in absorbance at 350 nm. Reaction mix contained compound, PKM2, ADP, PEP, NADH and LDH prepared in reaction buffer.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
442814
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000183179
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
134693700
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
N4JTA67V3O
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
C174739
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
2151847-10-6
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
SUB197489
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
FG-159
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY | |||
|
2595574
Created by
admin on Sat Dec 16 09:59:47 GMT 2023 , Edited by admin on Sat Dec 16 09:59:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD